Monaco Asset Management SAM
Monaco Asset Management SAM, managed by Anthony Stent Torriani, reported 36 positions worth $269.15M in its 2026 Q2 13F filing: 6 new and 27 closed.
Estimated return
Since 2025 Q2 the disclosed positions returned an estimated +87.9% against +34.4% for the S&P 500. Price-only return of the fund's top 100 US longs at each quarter start, vs the S&P 500 over the same windows. Not the fund's actual return (no trades, fees, shorts, derivatives, cash).
| Quarter | Fund | S&P 500 |
|---|---|---|
| 2025 Q2 | +7.4% | +11.4% |
| 2025 Q3 | +31.1% | +7.6% |
| 2025 Q4 | +15.6% | +3.1% |
| 2026 Q1 | +10.7% | -5.8% |
| 2026 Q2 | +4.3% | +15.5% |
Top holdings, 2026 Q2
| Ticker | Company | Value | Portfolio % | Change |
|---|---|---|---|---|
| BABA | ALIBABA GROUP HLDG LTD | $34.31M | 12.70% | +1330% |
| TDOC | TELADOC HEALTH INC | $26.86M | 10.00% | -21.4% |
| DEO | DIAGEO PLC | $23.20M | 8.60% | +16.1% |
| FISV | FISERV INC | $20.36M | 7.60% | +493% |
| SLV | ISHARES SILVER TR | $19.78M | 7.40% | NO CHANGE |
| VTRS | VIATRIS INC | $19.29M | 7.20% | -3.3% |
| MRVI | MARAVAI LIFESCIENCES HLDGS I | $13.92M | 5.20% | -34.8% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.58M | 3.90% | +516.5% |
| CSANY | COSAN S A | $10.56M | 3.90% | +9.9% |
| SDRL | SEADRILL LTD | $9.06M | 3.40% | +9.1% |
| NKE | NIKE INC | $8.83M | 3.30% | +258.3% |
| RCKT | ROCKET PHARMACEUTICALS INC | $8.48M | 3.20% | +20.5% |
| IAUX | I-80 GOLD CORP | $7.80M | 2.90% | NO CHANGE |
| NKTX | NKARTA INC | $6.72M | 2.50% | -5.9% |
| BIDU | BAIDU INC | $6.29M | 2.30% | -1.8% |
| CPRI | CAPRI HOLDINGS LIMITED | $6.26M | 2.30% | -34.3% |
| NVAX | NOVAVAX INC | $5.44M | 2.00% | -17.2% |
| BF.B | BROWN FORMAN CORP | $4.53M | 1.70% | -39.5% |
| HON | HONEYWELL INTL INC | $4.48M | 1.70% | NEW |
| JD | JD.COM INC | $4.46M | 1.70% | -12.5% |
| PLRX | PLIANT THERAPEUTICS INC | $2.21M | 0.82% | NO CHANGE |
| MOS | MOSAIC CO | $2.12M | 0.79% | NEW |
| ZM | ZOOM COMMUNICATIONS INC | $1.90M | 0.71% | NEW |
| GRWG | GROWGENERATION CORP | $1.77M | 0.66% | +2.1% |
| VNDA | VANDA PHARMACEUTICALS INC | $1.35M | 0.50% | -8.3% |
| SOXS | DIREXION SHARES ETF TRUST | $1.30M | 0.48% | NEW |
| QDEL | QUIDELORTHO CORP | $1.14M | 0.42% | -73.2% |
| BG | BUNGE GLOBAL SA | $1.07M | 0.40% | +47.3% |
| INGN | INOGEN INC | $1.04M | 0.39% | -8.5% |
| KRO | KRONOS WORLDWIDE INC | $964.08K | 0.36% | -16.5% |
| PTEN | PATTERSON-UTI ENERGY INC | $918.00K | 0.34% | -97.8% |
| LKFT | LAKEFRONT BIOTHERAPEUTICS NV | $767.49K | 0.29% | -7% |
| AGRO | ADECOAGRO S A | $573.00K | 0.21% | NEW |
| PRQR | PROQR THRAPEUTICS N V | $454.75K | 0.17% | -41.6% |
| ENPH | ENPHASE ENERGY INC | $211.53K | 0.08% | NEW |
| GMTL | GUARDIAN METAL RES PLC | $148.74K | 0.06% | -74.7% |
All funds · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.